John B. Pedersen

Smart Destinations, Inc. provides travel packages and services. It offers admission sightseeing passes in North American travel destinations. The company was founded by Cecilia Dahl, Kevin McLaughlin, Tyler Brooks and Ed Kim in 2003 and is headquartered in Boston, MA.

Access Closure, Inc. manufactures and distributes medical devices for cardiovascular and peripheral vascular markets. Its products include Mynx ace, Mynx grip, Mynx sealant technology and flash ostial system. The company was in founded in 2002 by Farhad Khosravi and is headquartered in Santa Clara, CA.

Neurolutions, Inc. develops revolutionary platform of devices, based on Brain Computer Interface (BCI) technology, which promise to restore function to patients who are disabled as a result of neurological injury. The company was founded by Eric Leuthhardt, Daniel J. Moran, and Gerwin Schalk on October 1, 2008 and is headquartered in St. Louis, MO.

Apama Medical, Inc. operates as a medical device company which focuses on the treatment of atrial fibrillation. The firm focuses on the electrophysiology market and offers a vastly superior catheter-based solution for the fastest growing market segment, atrial fibrillation ablation. The company was founded by Amr Salahieh in 2009 and is headquartered in Campbell, CA.

Axtria, Inc. provides customized analytics software and client consulting services. The firm?s solutions include decision science, commercial operations cloud and cloud information management. The company was founded by Jaswinder S. Chadha and Navdeep Chadha in 2010 and is headquartered in Berkeley Heights, NJ.

Lantos Technologies, Inc. develops intra-aural 3D ear scanning systems for the custom earpiece market. Its technology enables audiologists to eliminate the uncomfortable, messy, and error-prone technique that used to generate impressions of the ear canal. The firm provides 3D scanner that measures ear canal shape and tissue compliance to produce a map of the ear canal. It also offers noise protection devices for military and industrial markets, and consumer audio earphones. The company is headquartered in Wilmington, MA.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Lundbeckfond Invest A/S (Lundbeckfond Invest) is the investment management subsidiary of the Lundbeck Foundation in Denmark. Established in 1999, the firm is based in Copenhagen and manages the Lundbeck Foundation's investments, aiming for long-term, stable returns with moderate risk, such that the Foundation's net capital is not jeopardized and the Foundation is able to meet its commitments in terms of awarding grants and of laying a capital base for its subsidiaries.

C.W. Obel A/S provides investment services to industrial companies. The firm's financial assets are located in collaboration with independent financial advisor used by banks and pension companies. The company was founded by Christen Winther Obel in 1787 and is headquartered in Copenhagen, Denmark.

Clinical Innovations Europe Ltd. manufactures healthcare products for infants. It offers bayLance safety heelsticks, traxi Panniculus Retractor, ROM Plus Rupture of Membrane tests, edd Complete Tamponade System, Kiwi complete Vacuum Delivery System, Koala IUPC, and ClearView Uterine Manipulator. The company was founded in 1993 and is headquartered in Heathrow, the United Kingdom.

Imagitas, Inc. provides advertising, marketing and consulting services. It also provides direct mailing services through partnerships with state and federal government agencies. It was founded in 1992 by Brett H. Matthews and Chris Hessler and is headquartered in Waltham, MA.

TranS1, Inc. designs and develops surgical procedures and equipment for back pain. It is a medical device company focused on designing, developing and marketing products that implement its proprietary approach to treat degenerative conditions of the spine affecting the lower lumbar region. TranS1 currently markets the AxiaLIF family of products for single-level and two-level lumbar fusion and the Vectre and Avatar posterior fixation systems for lumbar fixation supplemental to AxiaLIF fusion. Its primary technology is AxiaLIF, a minimally invasive access and fusion system that enables lumbar fusion to be performed with complete preservation of the annulus and all paraspinal soft tissue structures. The company specializes in bringing innovative spine solutions to market, including AxiaLIF and AxiaLIF 2L+, technologies that allow surgeons to perform lower lumbar fusions that result in high fusion rates and low complication rates. The company is also developing a motion preservation platform to be delivered through this minimally invasive, trans-sacral approach. TranS1 was founded in May 2000 and is headquartered in Wilmington, NC.

Clinical Innovations LLC develops, manufactures and markets medical devices. It products include traxi Panniculus Retractor, ROM Plus Rupture of Membranes Test, ebb Complete Tamponade System, Koala Toco, Kiwi Complete Vacuum Delivery System, Koala IUPC, ClearView Uterine Manipulator and C-Snorkel Impacted Fetal Head Release. The company was founded in 1993 and is headquartered in Murray, UT.

Lundbeckfonden Ventures (Lundbeckfonden Ventures) is a venture capital firm wholly-owned by the Lundbeck Foundation. The firm was established in 2009 and is headquartered in Copenhagen, Denmark.

Ostial Corp. develops catheter-based delivery system combined with a bare metal stent. The firm allows physicians to perform aorto-ostial interventions with precision and predictability. The company was founded by Fred Khosravi in 2008 and is headquartered in Campbell, CA.

Incept LLC operates as a biotechnical research company. It focuses in the life-sciences space, and occasional involvement in select information technology opportunities. The company was founded in 1998 by Farhad Khosravi and Amarpreet S. Sawhney and is headquartered in San Mateo, CA.

Cydan LLC operates as an orphan drug accelerator that identifies and de-risks programs. The firm's model evaluates programs for treating rare diseases with unmet medical need and is aimed at creating new companies to develop those therapies. The company was founded by James G. McArthur in 2013 and is headquartered in Cambridge, MA.

Vtesse, Inc. provides novel drugs for life-threatening rare diseases. It developed VTS-270, a modified form of cyclodextrin that has been evaluated in preclinical and clinical studies at institutes within the National Institutes of Health (NIH) to treat patients with Niemann-Pick Disease Type C (NPC). The firm is working with the NIH and other leading academic centers to advance clinical study of VTS-270 for NPC, and to conduct pre-clinical discovery and development of other novel drugs for NPC and other LSDs. The company was founded by Ben Machielse in 2015 and is headquartered in Gaithersburg, MD.

VarmX BV is a spin-off from Leiden University Medical Center (LUMC) founded in 2016 by Professor Pieter Reitsma, a world-leading expert in hemostasis and thrombosis. VarmX is based in Leiden, NL. The Dutch company's lead compound, VMX-C001, is a modified recombinant blood factor X developed for the treatment of severe spontaneous bleeding and for the prevention of bleeding during urgent surgery in patients taking oral factor Xa inhibitors (FXa DOACs) as anticoagulation therapy. The company is supported by a strong syndicate of investors. Jan K. Öhrström has been the CEO of the company since 2018.

Instylla, Inc. operates as a biotechnology company. Its focus is to leverage hydrogel technology to create differentiated liquid embolics for interventional radiology with a specific initial focus on interventional oncology and peripheral hemostasis. The company was founded by Amarpreet Sawhney and is headquartered in Waltham, MA.

Tulavi Therapeutics, Inc. develops therapeutics to treat neurally mediated diseases. It helps to treat aberrant neural reflex arcs in peripheral and visceral diseases. The company was founded was founded by Corinne Bright, Fred Khosravi and Henry Chen and is headquartered in Mountain View, CA.

Abzu ApS provides technology services. It offers Abzu AI platform. The firm specializes in data, deep and machine learning, AI platform, cell based model, predictive problems and artificial general intelligence. The company was founded by Casper Skern Wilstrup in January 2018 and is headquartered in Copenhagen, Denmark.

Tiburio Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It provides novel treatments for rare neuroendocrine tumors and endocrine diseases. The company was founded by James Gregg McArthur in January 2019 and is headquartered in Cambridge, MA.

Imperative Care, Inc. is a healthcare technology company, which provides solutions to solve problems in stroke. It focuses on medical technology designed to expedite and improve the effectiveness of treatment, giving patients a chance for optimal recovery. The company is headquartered in Campbell, CA.

Rejoni, Inc. engages in the provision of biotechnology services. It focuses on developing products that improve the outcomes of minimally invasive and other gynecological surgical procedures. The company was founded in June 2020 and is headquartered in Bedford, MA.